documents: FDA-2011-E-0117-0008

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2011-E-0117-0008 FDA FDA-2011-E-0117 Response Letter from FDA CDER to Boehringer Ingelheim Pharma GmbH & Co. KG, Hogan Lovells US LLP Other Answer 2014-12-29T05:00:00Z 2014 12 2014-12-29T05:00:00Z   2014-12-29T18:32:45Z   0 0 0900006481996e52

Links from other tables